SecBot SecBot
144 ·Filed May 12, 2026

LNSR

LENSAR, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed5mo ago SEC0001949846-26-000268
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a de minimis proposed sale by a director with no executive role. No material signal for traders. Monitor for any subsequent Form 4 filings to confirm execution, but this filing alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
LNSR ▼ -2.47% at T+60d
NEUTRAL call -2.47% · α vs SPY -6.85% · entry $5.88 → $5.74
Entry = T+0 close
May 12, 2026
via day close
T+1d
-1.87%
call -1.87% · α -2.45%
$5.77
settled 6mo ago
T+5d
-4.25%
call -4.25% · α -4.33%
$5.63
settled 5mo ago
T+20d
-3.40%
call -3.40% · α -1.67%
$5.68
settled 5mo ago
T+60d
-2.47%
call -2.47% · α -6.85%
$5.74
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Director Thomas R. Staab II filed a Form 144 notice of intent to sell 850 shares of LENSAR common stock, with an estimated aggregate market value of $4,887.50. The sale is small relative to the company's $70M market cap and appears to be a routine, low-concern transaction by a director who is not an executive officer.

Key Facts

  • Director Thomas R. Staab II filed Form 144 on May 12, 2026, indicating intent to sell 850 shares.
  • Estimated aggregate market value of the proposed sale is $4,887.50.
  • Shares were acquired via open market purchase on December 6, 2022.
  • The sale represents a negligible fraction of the company's $70M market cap.
  • No recent insider buying or selling activity in the prior 30 days.

Financial Impact

Proposed sale of 850 shares worth approximately $4,887.50 — immaterial relative to $70M market cap.

dilution

Risk Factors

  • Insider selling could be perceived negatively by retail investors despite small size.
  • If the sale is executed and followed by additional insider sales, it may signal reduced confidence.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001949846-26-000268
Document: 0001949846-26-000268-index.html0001949846-26-000268
Document: 0001949846-26-000268.txt0001949846-26-000268
9 reports for LNSR
Performance horizon
80% Hit rate @ T+20 4 of 5 directional calls Went positive at some point 5 of 5 best @ T+20▲ +19.86%Sep 22, 2026
Filters
Rows
Reports for LNSR — sortable, filterable
TypeNow
Sep 22, 2026
5w ago
Institutional Cluster
BEARISH ★ 4/10
$7.25 $5.81▲ +19.86%▲ +19.30%$5.94 (+18.07%)
Aug 13, 2026
10w ago
8-K
BULLISH ★ 7/10
$8.27 $7.60▼ −8.10%▼ −6.35%$5.94 (−28.17%)
Jun 23, 2026
18w ago
DEFA14A
NEUTRAL ★ 2/10
$6.06 $5.75▼ −5.12%▼ −7.05%$5.94 (−1.98%)
May 12, 2026
24w ago
144
NEUTRAL ★ 2/10
$5.88 $5.68▼ −3.40%▼ −1.67%$5.94 (+1.02%)
May 8, 2026
24w ago
Press Release
BEARISH ★ 7/10
$5.64 $5.60▲ +0.71%▲ +0.73%$5.94 (−5.32%)
Apr 15, 2026
27w ago
8-K
BEARISH ★ 6/10
$5.80 $5.77▲ +0.52%▲ +6.33%$5.94 (−2.41%)
Mar 31, 2026
30w ago
8-K
BEARISH ★ 8/10
$5.96 $5.25▲ +11.91%▲ +21.34%$5.94 (+0.34%)
Mar 31, 2026
30w ago
Press Release
MIXED ★ 6/10
$5.96 $5.35▼ −10.23%▼ −19.66%$5.94 (−0.34%)
Mar 13, 2026
32w ago
8-K/A
NEUTRAL ★ 4/10
$9.85 $5.92▼ −39.90%▼ −43.49%$5.94 (−39.70%)
Showing 9 of 9

US Market Status

Market Closed — Opens Thu (11h 52m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 12, 2026